✦ LIBER ✦

Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate

✍ Scribed by Alan F. List; Thomas D. Kummet; Jonathan D. Adams; Hoo G. Chun

Book ID: 115683126
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 379 KB
Volume: 89
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(90)90358-k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor lysis syndrome in a chronic lympho

Tumor lysis syndrome in a chronic lymphocytic leukemia patient with pleural effusion after oral fludarabine and cyclophosphamide therapy

✍ Nakazawa, Hideyuki; Nishina, Sayaka; Mimura, Yuto; Kawakami, Toru; Senoo, Yasush 📂 Article 📅 2014 🏛 Carden Jennings Publishing 🌐 English ⚖ 972 KB

Severe respiratory syncytial virus pneum

Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia

✍ K. Field; M.A. Slavin; J.F. Seymour 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Tumor lysis syndrome (TLS) following flu

Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): Case report and review of the literature

✍ Kashif Hussain; Joseph J. Mazza; Lawrence H. Clouse 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB 👁 2 views

Tumor lysis syndrome in a case of chroni

Tumor lysis syndrome in a case of chronic lymphocytic leukemia induced by high-dose corticosteroids

✍ Coutinho, Anelisa K.; Santos, Marcelo de O.; Pinczowski, Hélio; Feher, Olavo; de 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 3 views

To the Editor: Schwachman's syndrome, a familial disease transmitted as an autosomal-recessive trait, is characterized by moderate chronic neutropenia, marked marrow hypocellularity, occasional thrombocytopenia and anemia, metaphyseal dysostosis of tubular bones, pancreatic fatty infiltration, and a

Tumor lysis syndrome after starting trea

Tumor lysis syndrome after starting treatment with Gleevec in a patient with chronic myelogenous leukemia

✍ A. Al-Kali; S. Farooq; A. Tfayli 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Risk factors for tumor lysis syndrome in

Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol

✍ Blum, K A; Ruppert, A S; Woyach, J A; Jones, J A; Andritsos, L; Flynn, J M; Rovi 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 356 KB